Clinical response and plasma concentrations of amitriptyline and its metabolite-nortriptyline in depressive patients

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 21, Issue 3, 1996, Pages 251-255

  Meljkovic B ^a,c   Pokrajac, M ^a   Timotijevic I ^b   Varagic V ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Institute for Mental Health   (Serbia)

^c Faculty of Pharmacy   (Serbia)

Author keywords

Amitriptyline; Clinical response; Correlation; Nortriptyline; Patients

Indexed keywords

AMITRIPTYLINE; NORTRIPTYLINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG METABOLISM; DRUG RESPONSE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; ORAL DRUG ADMINISTRATION; RATING SCALE; TREATMENT OUTCOME;

EID: 0030462288     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03189722     Document Type: Article

References (13)

1. Asberg M., Sjoqvist F. (1981) : Therapeutic monitoring of tricyclic antidepressants-clinical aspects. In: Richens A., Marks V. (Eds) Therapeutic Drug Monitoring. Edinburgh, Churchill Livingstone, pp. 224-238.
2. Pike E., Skuterud B. (1982) : Plasma binding variations of amitriptyline and nortriptyline. Clin. Pharmacol. Ther., 32, 228-234.
3. Asberg M., Cronhalm B., Sjoqvist F., Tuck D. (1971) : Relationship between plasma level and therapeutic effect of nortriptyline. BMJ, 3, 331-334.
4. Burrows G., Scoggins B.A., Tureek L.R., Davies B. (1974) : Plasma nortriptyline and clinical response. Clin. Pharmacol. Ther., 16, 639-644.
5. Braithwaite R.A., Goulding R., Theano G., Bailez J., Coppen A. (1972) : Plasma concentration of amitriptyline and clinical response Lancet, 1, 1297-1300.
6. Ziegler V.E , Tee Co B , Tazlor J.R., Clazton P.J., Biggs T. (1976) : Amitriptyline plasma levels and therapeutic response. Clin. Pharmacol. Ther., 19, 795-801.
7. Kupfer D.J., Hanin I., Spiker D.G., Grau T., Coble P. (1977) : Amitriptyline plasma levels and clinical response in primary depression. Clin. Pharmacol. Ther., 22, 904-911.
8. Amsterdam J., Brunswick D., Mendels J. (1980) : The clinical application of tricyclic antidepressant pharmacokinetics and plasma levels. Am. J. Psychiatry, 137, 653-662.
9. Edelbroek P.M., Zitman F.G., Schreuder J.N., Rooymans H.G.M., De Wolff F.A. (1984) : Amitriptyline metabolism in relation to antidepressive effect. Clin. Pharmacol. Ther , 35, 467-473.
10. Scoggins B.A., Maguire K.P., Norman T.R., Burrows G.D. (1980) : Measurement of tricyclic antidepressants Part I. A review of methodology. Clin. Chem., 26, 5-17.
11. Pokrajac M., Miljković B., Timotijević I. (1994) : How does lithium influence amitriptyline/nortriptyline plasma levels, pharmacokinetics and effect in depressive patients on amitriptyline-lithium therapy? Eur. J. Drug Metab. Pharmacokinet. Special Issue (Proceedings of the fifth European Congress of Biopharmaceutics and Pharmacokinetics), 19, 189-193.
12. Timotijević I., Zdravković M., Pokrajac M., Miljković B., Stojković M., Marinković O. (1995) : Correlation of mono and combined amitriptyline/lithium therapy with therapeutic and side effects. J. Trace Microprobe Tech., 13, 11-20.
13. Coppen A., Ghose K., Montgomery S. et al. (1978) : Amitriptyline plasma concentration and clinical effect - World Health Organization Collaborative Study. Lancet, 1, 63-66.